Tendinopathy achilles.avi pathology 20index
Echometrix logo medsq

Echometrix, LLC

Echometrix is commercializing patented ultrasound technology that will catalyze penetration of the $1 billion musculoskeletal ultrasound market.

  • Stage Product In Development
  • Industry Medical Devices and Equipment
  • Location Madison, WI, USA
  • Currency USD
  • Founded July 2007
  • Employees 2
  • Website echo-metrix.com

Company Summary

Echometrix has developed a proprietary ultrasound technology to facilitate non-invasive diagnosis and treatment management of tendon and ligament injuries. Our product, the Echosoft, is ultrasound image-processing software designed to lower costs and improve outcomes for everyday injuries, elite athletes, and equine veterinary patients. The company is seeking a partner to license or acquire the technology to bring it to its full potential.


  • Jeffrey Dalsin, PhD, is Chief Executive Officer of Echometrix. In 2006, Prior to joining Echometrix, Jeff served as Research and Development Manager at Kensey Nash Corporation after the acquisition of Nerites Corporation by Kensey Nash in January 2011 for $20M. Prior to his tenure with Kensey Nash, Jeff served as Director of Product Development at Nerites, commercializing a technology that he co-invented and developed during his doctoral work at

  • B7d28348 08a2 4114 a416 43b2214551de
    Chief Medical Officer

    Dr. Kenneth S. Lee is currently Director of MSK Ultrasound at the University of Wisconsin Hospital and Clinics. Dr. Lee graduated from the University of Michigan, after which he matriculated at Tufts University School of Medicine's Dual-Degree Program graduating in 2002 with both a MD and a MBA. He serves as Chair of the American Institute of Ultrasound in Medicine (AIUM) MSK Ultrasound Group and is a member of the Board of Directors of the AIUM.


  • Default avatar
    AlphaTech, S.C., Madison
    Default avatar
    Tom Milliken, SVA, Madison

Previous Investors

  • Default avatar
    Individual Angel Investors